Search the Newsreel

McKesson signals next phase for MMS with new name

McKesson's Medical-Surgical Solutions business will formally operate as Wellverse starting in January 2027, according to CEO Brian Tyler. This rebranding aims to establish a distinct market identity and reflects the company's ongoing phased transition towards separation. The company also reported Q1 fiscal year 2027 …

PensionDanmark Pensionsforsikringsaktieselskab Grows Stake in McKesson Corporation $MCK

PensionDanmark Pensionsforsikringsaktieselskab increased its stake in McKesson Corporation by 8.9% in the second quarter, bringing its total holdings to 30,850 shares valued at $23.3 million. This increase comes as McKesson reported strong fiscal first-quarter results, with adjusted EPS and revenue exceeding analyst expectations, and …

McKesson (MCK) Stock Pauses Despite Higher Guidance And EPS Strength

McKesson Medical-Surgical is becoming Wellverse, keeping RVA headquarters

McKesson Medical-Surgical, a major healthcare employer in Richmond, is rebranding as Wellverse in January 2027 as it moves towards becoming an independent, publicly traded company. The new name reflects its mission to unify healthcare supply and support, allowing providers to focus on patient care. …

McKesson Corporation Stock 12‑Month Price Target Raised to $985.4, Implies 12% Upside

Analysts have raised the 12-month average price target for McKesson Corporation (MCK) stock to $985.4, up from $953.07, implying a 12% upside based on the Aug. 5 closing price. The target range for the stock is between $812 and $1080 per share. The consensus …

Henrico’s McKesson Medical-Surgical plans 2027 IPO

Henrico County-based McKesson Medical-Surgical, a subsidiary of McKesson, announced plans for a 2027 IPO and will rebrand as Wellverse in January 2027. The company, which provides medical supplies and services to over 336,000 customers, was recently valued at $13 billion after selling a minority …

COLUMBUS MCKINNON CORP SEC Filing (Aug 6, 2026)

This article reports on an SEC Form 144 filing by COLUMBUS MCKINNON CORP (CMCO) on August 6, 2026. The filing indicates a proposed sale of 12,000 shares of common stock acquired through a stock option exercise, with an aggregate market value of $254,723.26, to …

Mizuho Adjusts Price Target on McKesson to $905 From $885

Mizuho has increased its price target for McKesson (MCK) to $905 from $885, as reported on August 6, 2026. This adjustment follows a series of similar price target updates from other financial institutions on the same day, indicating a potentially shifting outlook for the …

Mckesson Corp Stock (MCK) Moved Down by 3.44% on Aug 6: What Signal Does It Send?

McKesson Corp (MCK) stock fell by 3.44% due to a contraction in operating margins within its U.S. Pharmaceutical segment and management's decision to maintain, rather than raise, full-year earnings guidance. The company also faces challenges from increased capital expenditure, regulatory scrutiny on drug pricing, …

McKesson debuts Wellverse name for Medical-Surgical Solutions business

McKesson has announced that "Wellverse" will be the new name for its future standalone Medical-Surgical Solutions business. This move is part of the company's planned separation, supported by a $2.25 billion Term Loan B facility and a previous $1.25 billion minority interest sale to …

MCK Q1 Earnings Call Centers on Pharma-Led Guidance Raise

McKesson Corporation MCK used its first-quarter fiscal 2027 call to frame the year around stronger North American Pharmaceutical execution, specialty demand and disciplined reinvestment. Management raised full-year adjusted earnings guidance after the segment delivered 19% operating profit growth. Adjusted earnings of $9.93 per share …

McKesson price regains footing - Forecast today - 06-08-2026

McKesson Corporation (MCK) closed higher, continuing its recovery with positive momentum after establishing a higher low. The stock remains in a short-term bullish corrective trend, trading above its 50-day Simple Moving Average, and momentum indicators show a bullish divergence. The outlook is bullish, targeting …

Canandaigua National Bank & Trust Co. Invests $1.56 Million in McKesson Corporation $MCK

Canandaigua National Bank & Trust Co. has invested $1.56 million in McKesson Corporation, purchasing 2,071 shares during the second quarter. McKesson exceeded quarterly expectations with adjusted EPS of $9.93 and revenue of $105.38 billion, and has raised its fiscal 2027 adjusted EPS guidance. The …

Renaissance Technologies LLC Acquires 258,238 Shares of Columbus McKinnon Corporation $CMCO

Renaissance Technologies LLC significantly increased its stake in Columbus McKinnon Corporation (NASDAQ:CMCO) by 232.5% in the first quarter, purchasing 258,238 additional shares, bringing its total holdings to 369,323 shares valued at approximately $5.4 million. The industrial products company recently reported strong quarterly earnings of …

Informe de resultados de McKesson: supera las estimativas del primer trimestre de 2027 y mejora sus perspectivas

¿Está el crecimiento de los ingresos de McKesson, junto con la caída del beneficio por acción, alterando el argumento de inversión a favor de McKesson (MCK)?

McKesson Kicks Off Fiscal 2027 With Solid Results Underpinned by Specialty and Margin Strength

McKesson, a leading pharmaceutical wholesaler, reported solid results for the start of fiscal 2027, driven by strong performance in its specialty segment and robust margins. The company, alongside Cardinal Health and Cencora, forms an oligopoly controlling over 90% of the U.S. drug distribution market. …

McKesson Medical-Surgical to keep local HQ after spin off from parent company, rebranding as Wellverse

McKesson Medical-Surgical, currently headquartered in Henrico, plans to rebrand as Wellverse and maintain its local headquarters after spinning off from its parent company, Texas-based McKesson Corp. The medical supplies distributor, which employs about 1,000 people in the Richmond area, aims to become an independent, …

Is McKesson’s Revenue Growth With Falling EPS Altering The Investment Case For McKesson (MCK)?

McKesson Corporation reported increased sales but decreased net income and diluted EPS in Q1 2026, indicating margin pressures despite revenue growth. This situation raises questions about the company's long-term earnings profile and its ability to maintain profitability amidst evolving healthcare policies, even as management …

Columbus McKinnon Names New Chief Financial Officer

Columbus McKinnon has appointed John R. Linker as Executive Vice President and Chief Financial Officer, effective July 1, 2026. Thomas Oddo, formerly VP and Corporate Controller, has been elevated to Chief Accounting Officer. An analyst has a Buy rating on CMCO stock with a …

McKesson raises 2026 profit outlook as FQ1 beats on both lines

[Q2 second quarter business report infographic data] cagkansayin * McKesson (MCK [https://seekingalpha.com/symbol/MCK]) raised its fiscal 2027 full-year EPS guidance as its Q2 financial results beat on both lines. * The pharmaceutical products wholesaler now sees FY27 non-GAAP EPS of $44.20-$45.00, up from $43.80-$44.60 prior. …

McKesson (MCK) Q1 Earnings and Revenues Top Estimates

McKesson (MCK) came out with quarterly earnings of $9.93 per share, beating the Zacks Consensus Estimate of $9.44 per share. This compares to earnings of $8.26 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings …

Informe de resultados de McKesson: supera las estimaciones del primer trimestre de 2027 y mejora sus perspectivas

McKesson (MCK) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates

For the quarter ended June 2026, McKesson (MCK) reported revenue of $105.38 billion, up 7.7% over the same period last year. EPS came in at $9.93, compared to $8.26 in the year-ago quarter. The reported revenue compares to the Zacks Consensus Estimate of $104.39 …

McKesson’s (NYSE:MCK) Q2 CY2026 Sales Top Estimates

McKesson (NYSE:MCK) reported strong Q2 CY2026 results, exceeding revenue and adjusted EPS estimates with sales up 7.7% year-on-year to $105.4 billion and non-GAAP profit of $9.93 per share. The company slightly raised its full-year Adjusted EPS guidance and demonstrated satisfactory revenue growth, although its …

McKinley Acquisition (MKLY) to merge with Space-Eyes in $275M stock deal plus PIPE

Mckesson Corp Stock (MCK) Closed Up by 5.08% on Aug 5: What Investors Need To Know

McKesson Corp (MCK) saw its stock price rise by 5.08% on August 5th, following a fiscal first-quarter earnings report that surpassed consensus expectations. The company's strong performance was driven by its U.S. Pharmaceutical segment and an upward revision of its full-year earnings guidance, especially …

McKesson Reports Fiscal 2027 First Quarter Results and Raises Full Year Adjusted EPS Guidance

McKesson Corporation announced its fiscal 2027 first quarter financial results and raised its full-year adjusted EPS guidance. The company will host an earnings conference call for investors, and further details and financial information are available on McKesson's Investor Relations website. McKesson is a diversified …

(MCK) McKesson Now Expects Fiscal 2027 Adjusted EPS Range $44.20-$45.00, vs. FactSet Est of $44.26

McKesson (MCK) has updated its fiscal year 2027 adjusted EPS outlook, now expecting a range of $44.20 to $45.00. This new guidance compares favorably against the FactSet estimate of $44.26. The revised forecast follows McKesson's strong fiscal Q1 results, which saw adjusted earnings and …

McKesson earnings up next: Can revenue rebound after Q4 miss? By Investing.com

McKesson is set to release its fiscal first-quarter earnings, with investors closely watching for a rebound in revenue after a significant miss in the prior quarter. Analysts expect robust earnings and revenue growth, but the stock has experienced recent volatility due to concerns about …

McKesson raises annual profit forecast on strong growth in specialty drug business

McKesson has raised its annual profit forecast for fiscal 2027 after outperforming first-quarter earnings estimates, driven by strong growth in its oncology and specialty drug businesses. The company now expects adjusted profit between $44.20 and $45 per share, exceeding previous projections and analyst expectations. …

MCKESSON ($MCK) Releases Q1 2027 Earnings

Empowered Funds LLC Raises Stake in Columbus McKinnon Corporation $CMCO

Empowered Funds LLC significantly increased its holdings in Columbus McKinnon Corporation (NASDAQ:CMCO) by 122.6%, now owning 262,129 shares valued at $3.8 million. This comes as Columbus McKinnon reported strong quarterly earnings, beating analyst expectations with $0.61 EPS and a 125.3% revenue increase. Despite mixed …

Overland Park company announces layoffs to ‘streamline’ operations

Rx Savings Solutions, an Overland Park-based company specializing in prescription price transparency and owned by McKesson Corporation, has announced layoffs to streamline operations and focus on growth. While the exact number of affected employees was not disclosed, the company has not filed a WARN …

Columbus McKinnon names John R. Linker CFO, principal financial officer effective July 31

Columbus McKinnon has appointed John R. Linker, 51, as its principal financial officer, effective July 31, 2026. He also assumed the role of executive vice president and chief financial officer on July 1, 2026. Additionally, Thomas Oddo was named chief accounting officer on the …

Space-Eyes, Inc. (MKLY) plans SPAC merger and $75M note financing